Graves Disease
Cannabis is being explored as a complementary therapy for managing symptoms associated with Graves’ disease, an autoimmune disorder that affects the thyroid gland, leading to hyperthyroidism. Cannabinoids such as cannabidiol (CBD) exhibit anti-inflammatory and immunomodulatory properties, which may help reduce the autoimmune response that drives Graves’ disease (Kaplan et al., 2003).
CBD’s ability to suppress the production of pro-inflammatory cytokines could alleviate symptoms like swelling and discomfort caused by inflammation of the thyroid or surrounding tissues (Carrier et al., 2006).
Additionally, cannabis has shown promise in reducing anxiety, tremors, and insomnia, which are common symptoms experienced by those with Graves’ disease (Blessing et al., 2015).
Although cannabis cannot directly address the thyroid hormone imbalance characteristic of Graves’ disease, it may offer symptomatic relief, enhancing the quality of life for patients. However, more research is needed to determine the long-term effects of cannabis use in this context, especially regarding its interaction with standard treatments like antithyroid medications and radioactive iodine therapy.
References
- 1. Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015). Cannabidiol as a potential treatment for anxiety and related disorders. Neurotherapeutics, 12(4), 825-836.
- 2. Carrier, E. J., Auchampach, J. A., & Hillard, C. J. (2006). Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proceedings of the National Academy of Sciences, 103(20), 7895-7900.
- 3. Kaplan, B. L., Springs, A. E., & Kaminski, N. E. (2003). The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT). Journal of Neuroimmune Pharmacology, 25(4), 431-441.
- 4. McPartland, J. M., & Guy, G. W. (2017). The evolution of cannabis and coevolution with the cannabinoid receptor—a hypothesis. Planta Medica, 83(12/13), 201-211.
- 5. Klein, T. W. (2005). Cannabinoid-based drugs as anti-inflammatory therapeutics. Nature Reviews Immunology, 5(5), 400-411.
Related Services
Cannabis has garnered attention as a potential adjunct therapy for bipolar disorder, offering therapeutic benefits when used…
Cannabis has emerged as a complementary option in managing cancer-related symptoms, providing…
Cannabis has shown promise as a therapeutic option for managing Crohn’s disease, a chronic…
Cannabis has gained recognition as a potential therapy for managing chronic pain, offering relief…
Cannabis is being explored as a potential adjunct therapy for managing depression, offering…
Cannabis, particularly cannabidiol (CBD) has shown significant promise in managing epilepsy,…
Cannabis has been explored as a potential treatment for glaucoma, a condition characterized…
Cannabis is being studied as a potential therapy for managing pain associated with gout, a form of…
Cannabis has demonstrated potential in improving the quality of life for individuals living with..
Cannabis has been studied for its potential to help manage hypertension (high blood pressure), a…
Cannabis has gained as a potential treatment for Irritable Bowel Syndrome (IBS), a gastrointestinal disorder…
Cannabis has gained attention as a potential treatment for insomnia, a common sleep disorder..
Cannabis has shown potential in the treatment of migraines, a neurological condition characterized…
Cannabis has shown potential as a therapeutic option for managing symptons of multiple sclerosis (MS), a chronic…